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Abstract
Background: Atypical lipomatous tumours (ALT) are common adipocytic tumours. Due to their large size and deep-
seated location, wide resection might result in severe functional deficits. The question which margins should be aimed
is hence discussed controversially.
Methods: Forty consecutive patients underwent limb-sparing resections. Margins were defined as R0 (wide resection),
R1 (marginal resection) or R2 if tumour was left. All patients were followed for evidence of local recurrence or remote
metastases. Overall and recurrence-free survival was calculated.
Results: The mean age at the time of surgery was 61.9 years. The mean tumour diameter was 17 cm with no patient
having metastatic disease. In 8 cases a wide (R0) resection, in 31 cases a marginal (R1) and in one patient a R2-resection
was performed. The median follow-up time was 40 months. Four patients died due to causes that were not tumour-
related. 3 (7.5%) patients (all R1) developed local recurrences. Two of our 3 recurrences in this series occurred in 6 already
recurring cases. We observed no dedifferentiation of tumours and no metastatic disease.
Conclusions: ALT represents a comparatively common diagnosis in large deep-seated lesions of the extremities,
especially in patients over 60 years. Marginal resection shows an acceptable rate of local recurrence. The risk of
dedifferentiation as proven also in a metaanalysis of the English literature of the last 30 years is close to 1%, metastatic
disease is exceedingly rare.
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Background
Well into the 1970s, the term “well-differentiated liposar-
comas” was used to describe a class of adipocytic soft tis-
sue tumours with local aggressive behavior but typically
without metastatic spread. Based on this particular behav-
ior, they have been renamed as “atypical lipomatous
tumours (ALT)” or “atypical lipomas” if seen in the
extremities or at the trunk where complete surgical exci-
sion is easier achievable than in a retroperitoneal location
[1, 2]. In body regions that are more difficult to access sur-
gically and where local recurrence is common and where
a lethal outcome is possible without dedifferentiation of
the tumour or metastatic disease, the term “well-
differentiated liposarcoma (WDLS)” is still more appropri-
ate [3, 4]. ALTs are with a frequency of 40–45% the most
common adipocytic tumours, often seen after the fifth dec-
ade of life with a slight male predominance [3, 5]. Growing
slowly this may result in comparatively large tumours.
On the benign side of the spectrum, large deep-seated
lipomas do not show an overexpression of MDM2 and
CDK4, thus allowing for a clear histopathological dis-
tinction from more aggressive lesions.
So the decision whether to classify a histolopathologically
well-differentiated liposarcoma as an ALT or as a WDLS is
mainly based on tumour location and surgical resectability
and reflects the course of the disease with respect to the in-
cidence of dedifferentiation and distant metastases [6].
Based on their typically large size and deep-seated lo-
cation, a wide resection might result in severe functional
deficits. So a controversial discussion about what type of
margins (marginal vs wide resection) should be aimed
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for and whether adjuvant radiotherapy might reduce the
risk of local recurrence is still ongoing [7]. This study re-
flects the experience of treating these lesions at a referral
sarcoma center.
Methods
From 1988 through 2015, 40 consecutive patients with
ALT of the extremities and the trunk were treated at our
institution, 39 of them after 2002. All tumours were lo-
cated deep to the fascia and had a diagnosis of ALT based
on histopathological features and immunohistochemistry.
In terms of preoperative imaging, predominantly mag-
netic resonance imaging (MRI) and in some cases com-
puted tomography (CT) was used to define size and
precise location of the tumour. A CT scan of the chest
was the standard study to exclude metastatic disease.
All patients underwent limb-sparing surgical resection.
The margin was defined as R0 if a rim of sound tissue
around the lesion was present (wide resection) or R1 if the
margins were contaminated but the tumour capsule with
the latter remaining closed (marginal resection). In few se-
lected patients, part of the tumour was left as part of the
surgical strategy and these were classified as a R2 resection.
In all cases, we performed an MDM2 and CDK4 im-
munostaining as surrogate marker for MDM2 gene
amplification. In ambivalent cases MDM2 fluorescent in
situ hybridization (FISH) analysis was performed (Fig. 1).
All patients were followed for evidence of local recur-
rence or distant metastases in general by MRI scans and
chest x-rays.
For statistical analysis, overall and recurrence-free sur-
vival were calculated according to the Kaplan-Meier
method. Significance analysis was performed using the
Log-Rank Test or the Chi-Square Test. The data analysis
software used was MedCalc®.
Results
This series
The mean age of the 21 male and 19 female patients was
61.9 years (range: 9–86). The lower extremity was in-
volved in 33 cases (29 thigh, 4 lower calf ), the upper and
lower arm in 1 each, the axilla in 2 and the trunk in 3 pa-
tients. The mean tumour size was 17 cm (range: 4–65).
The mean duration of symptoms prior to surgery was
26 months (range, 1–323): 38 (95%) patients complained of
swelling, 11 (28%) of pain. Neurological impairment (sen-
sory) or restriction of movement was seen occasionally.
Two patients were diagnosed as a consequence of ruling
out a suspected deep vein thrombosis. Thirty-one patients
had a biopsy taken at our institution or existing histopath-
ology studies from previous surgeries. Local recurrence
after surgery at other institutions was seen in 6 cases and
occurred at a mean of 15 months after the preceeding sur-
gery. No patient had evidence of metastatic disease.
In 8 cases a wide (R0) resection, in 31 a marginal (R1,
Figs. 2 and 3) and in one patient with recurrent disease
after 5 previous surgeries (71 years old, involvement of
the sciatic nerve) a R2-resection was performed. Surgical
complications included transient motor deficits in 3 pa-
tients, prolonged wound healing in 3, hematoma in 3,
one infection and lymphedema in one patient. In 4 pa-
tients an adjuvant radiotherapy was performed. Two of
these patients suffered from recurrent lesions and two
from primary disease with infiltration of critical struc-
tures and marginal resections.
The median follow-up time was 40 months (range,
2–151). Nine patients had a follow-up of less than
Fig. 1 Fluorescent in situ hybridization (FISH) analysis with MDM2
amplification with clusters of green signals. Centromer is red
Fig. 2 A T2-weighted MRI scan shows an atypical lipoma in the
dorsal aspect of the thigh in an 81-year old patient. The sciatic nerve
(*) and the major vessels (+) are close to the tumour
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9 months whereas 13 had a follow-up of more than
60 months. Four patients died due to non-tumour-
related causes.
The 5-year local recurrence free survival in this cohort
was 95%. In total, 3 (7.5%) patients developed local re-
currences at 7, 44 and 62 months after surgery, respect-
ively (Fig. 4). All three patients had a marginal (R1)
resection (n.s.). One of the patients had re-resection and
is currently tumour-free 9 years after the second resec-
tion. Another patient has a small recurrence (after his
4th surgery) without any symptoms and is under “watch-
ful waiting” 6 years after surgery. The third, an 89-year
old patient with 14 prior surgeries and with severe heart
disease has mild symptoms and has elected not to
undergo further surgery (Fig. 5). We observed no case of
dedifferentiation and no metastatic disease during their
follow-up. In comparison to the rest of the cohort, these
three patients had larger tumours (mean 26 compared
to 16 cm, n.s.). Two of the 3 recurrences occurred in 6
already recurrent cases and only one after the 34 pri-
mary resections (Fig. 6, p = 0,0285). Out of the 4 irradi-
ated cases none developed local recurrence (n.s.).
Literature
In addition, the English literature of the last 30 years in-
cluding series with more than 10 cases was reviewed in
detail. The results are summarized in Table 1. In total,
1143 patients are described in the papers reviewed. In
1043 of these patients, the margin status was mentioned.
59% of these cases had a marginal and 41% had a wide re-
section. Regarding local recurrence, information could be
extracted in 701 of the patients with defined margins.
Local recurrence developed in 17% of the marginally
resected and in 7% of the wide resected patients (p < 0.05).
In the whole group of 1143 patients, local recurrence was
seen in 174 (15%) cases. Of these patients 14 (8%) devel-
oped a dedifferentiation in the context of local recurrence.
No patient in the whole group was shown to have devel-
oped metastatic disease. The mean time until recurrence
was 5.5 years and in 6 of 10 studies the mean time until
local relapse was greater than 5 years.
Discussion
The classification of well-differentiated lipomatous tu-
mours of the extremity and the trunk wall was clarified
in the last edition of the WHO manual in 2013 [3]. The
term “Atypical Lipoma” is well defined and accepted.
Still, controversy exists regarding the rate of local recur-
rence, dedifferentiation, metastatic disease, surgical mar-
gins and adequate follow-up time as well as treatment
regimen. Well-differentiated liposarcomas account for
approximately 50% of all liposarcomas and are hence
seen relatively often [8]. The long duration of symptoms
(in this study: mean > 2 years, up to more than 20 years)
indicates the low aggressiveness of the tumour. The
raised average age of 62 years and the fact that nearly
75% of the patients developed the tumour in the thigh
underlines the slow growth potential in large soft-tissue
compartments where clinical symptoms are less
Fig. 3 Same patient as Fig. 2. The tumour has been marginal resected
keeping the sciatic nerve and the major vessels
Fig. 4 Local recurrence-free survival in 40 patients with ALS
Fig. 5 A T2-weighted MRI scan shows an atypical lipoma in the
dorsal aspect of the thigh in an 85-year old patient. This was the
13th local recurrence of the tumour classified always as “lipoma”
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noticeable. In many of our cases, MRI proved the lesion
either to be an atypical lipoma or a lipoma. Thickened
or nodular septa (> 2 mm), non-adipose masses within
the tumour, foci of T2-weighted signal lesions, promin-
ent contrast enhancement and size greater than 5 cm
have been described as useful to differentiate both le-
sions from each other [9–12]. Core needle biopsy with
subsequent murine double-minute 2 (MDM2) and
cyclin-dependent kinase 4 (CDK4) [13–15] analysis
might provide more diagnostic accuracy before surgery
Fig. 6 Local recurrence-free survival in 34 patients with primary ALS and 6 patients with recurrent disease (p = 0,0285)







Author Year Patients (n) Wide Resection Marginal Resection Total
Azumi et al. [20] 1987 24 7/24 29% 0/7 0% 0
Weiss et al. [6] 1992 46 20/46 43% 3/20 15% 0
Lucas et al. [25] 1993 32 1/9 11% 14/23 61% 15/32 47% 1/15 7% 0 7
Rozental et al. [28] 2002 31 1/9 11% 15/22 68% 16/31 52% 4/16 25% 0 4,7
Kooby et al. [24] 2003 91 0/28 0% 5/63 8% 5/91 5% 3/5 60% 0 6,8
Bassett et al. [23] 2004 51 0/0 14/51 27% 14/51 27% 1/14 7% 0 4
Sommerville et al. [22] 2005 61 0/0 5/61 8% 5/61 8% 0/5 0% 0 3,2
Evans et al. [21] 2007 11 1/11 9% 0/1 0% 0
Zagars et al. [31] 2007 15 8/15 53% 0/8 0% 0
Billing et al. [5] 2008 51 4/51 8% 4/51 8% 0/4 0% 0 6,8
Mavrogenis et al. [17] 2011 47 0/8 0% 5/39 13% 5/47 11% 1/5 25% 0 6,1
Yamamoto et al. [8] 2012 40 0/34 0% 0/6 0% 0/40 0% 0/0 0% 0
Fisher et al. [32] 2013 63 59 4 14/63 22% 0/14 0% 0
Mussi et al. [33] 2014 171 5/95 5% 11/76 14% 16/171 9% 0/16 0% 0
Cassier et al. [26] 2014 283a 158 121 26/283 9% 0/26 0% 0
Kito et al. [29] 2015 41 7/11 64% 0/30 0% 7/41 17% 1/7 14% 0 7,9
Chang et al. [7] 2016 45 1/11 9% 7/34 21% 8/45 18% 0/8 0% 0 5,3
Current study 40 0/8 0% 3/32 9% 3/40 8% 0/3 0% 0 3,1
Total 1143 15/213 7% 430 83/488 17% 613 174/1143 15% 14/174 8% 0 5,5
aIncluding patients with unknown margin status
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[16]. However, due to the fact, that both lesions require
the same marginal resection in our assessment, we de-
cided for surgery without biopsy in the radiologically
typical cases. Therefore, biopsy was only occasionally
performed and especially in those patients at the begin-
ning of this series.
We report an incidence of local recurrence that is half
of what has been shown in several other studies with
marginal resections. The most probable explanation for
this difference in our view is the median follow-up time
of 40 months. Only 13 out of 40 patients had a follow-
up of more than 60 months. Taking into account that
local recurrence developed in most of the other studies
in patients more than 60 months after surgery, it is likely
that our local recurrence rate will increase over time and
this represents a limitation of our study. There is data
indicating that the risk of local recurrence is correlated
with the time of follow-up [17].
Our data also significantly supports the observation
that local recurrence is more often seen in patients who
already have recurrent disease [17]. In addition, a statis-
tically significant correlation between local recurrence
and marginal or wide resection is evidenced in the litera-
ture (Tab. 1). Due to the fact, that most patients have
large tumours in close proximity to major vessels or
nerves, a wide resection carries a considerable risk of
major functional problems and / or complications.
Taking into account that dedifferentiation developed
only in 14 out of 1143 patients (1.2%) and metastatic
disease was not seen in any of the described series, a
more aggressive management including wide resections
or re-excisions after primary marginal resections seems
unreasonable [16]. Also in recurrent cases with close
proximity to major nerves or blood vessels, re-resection
is possible without substantial morbidity [18]. There are
some case reports or small series of patients indicating
that dedifferentiation in local recurrence might increases
the risk of metastatic disease [5, 17, 19–24].
Dedifferentiation most probably occur only in a
small subregion of the tumour surrounded by well-
differentiated tumour which supports the concept of sur-
gical removal and entails a much better prognosis than
with other dedifferentiated sarcomas [25]. Even recurring
dedifferentiated tumours might again exhibit better differ-
entiation [6]. Dedifferentiation is much more common in
retroperitoneal (17%) or groin (28%) lesions [6]. This
should be taken into account in large extremity tumours
extending into the pelvis or the retroperitoneum. Weiss et
al., as stated before, mentioned that dedifferentiation
which is more often seen in central locations might be not
site-dependent, but rather time-dependent. In those
locations, the tumour might grow undetected for lon-
ger times. In contrast, the experience with large and
slowly growing extremity tumours as in our and
many other series might in fact prove a true site-
dependency.
Radiation therapy did not affect the outcome in this
small series of patients with only 4 irradiated cases (no
recurrence). In general, radiation therapy is effective in
reducing local recurrence in R1-resections (74%) [26, 27]
but the question remains, whether adjuvant radiation is
necessary if the relapse could be marginally re-resected.
Radiation therapy does not affect overall survival [26].
So Cassier et al. conclude that a wait-and-see policy
could be adopted for R1- and R2-resected patients pro-
vided that a potential reoperation is both feasible and
reasonable [26]. However, radiotherapy should be con-
sidered especially in recurrent cases where even mar-
ginal resections might produce severe functional deficits.
Follow-up time is crucial in this entity. Some authors
propose a minimum of 5 years [22, 28], which in the
light of the published data with a mean time to relapse
of 5.5 years appears too short. As follow-up is increased
in most studies, more and more recurrences are de-
tected. The recommended observation period is hence
suggested as being 8 years by some authors [29]. There
are studies which show a mean time to local relapse of
16 years [8] in later re-resected patients. Regular long-
term follow-up is therefore required especially in recur-
rent cases and should clearly exceed 5 years. We would
propose 10 years in total. Whether this is done in a bian-
nually fashion in the first 6 years and annually later as
proposed [28] or in a different scheme is controversial.
Due to the very low risk of dedifferentiation, clinical ob-
servation only is also regarded as being sufficient by
some authors [5]. The patient may be advised to exam-
ine him- or herself. This is underlined by data showing
that in most local recurrences of soft-tissue sarcomas of
the extremities, the patient notices them earlier than the
investigators in routine follow-up [30].
Conclusions
ALT represents a typical diagnosis in large deep-seated le-
sions of the extremities, especially in patients over 60 years
of age. There are several characteristics in MRI as thick-
ened septa (> 2 mm), non-adipose masses, foci of T2-
weighted lesions and contrast enhancement differentiating
them from lipomas. Marginal resection of the tumour
while trying to maintain the thin capsule around the lesion
and only opening the tumour if necessary for the prepar-
ation of major vital structures shows an acceptable rate of
local recurrence. The risk of dedifferentiation is close to
1% and metastatic disease is exceedingly rare.
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